Evidence map›Paper›PMID 33689454›Full record

Trial reportDiabetes technology & therapeutics2021

Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System.

Melissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, Marc D Breton, Katrina J Ruedy, Laya Ekhlaspour, Gregory P Forlenza, Erin C Cobry, Laurel H Messer, Eda Cengiz and 14 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Diabetes technology & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03844789 (The International Diabetes Closed Loop), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03844789 nacompletednot on this map

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas in Pediatrics: A Study of t:Slim X2 With Control-IQ Technology

TypeinterventionalSponsorUniversity of VirginiaRan2019 to 2020Enrolled101ConditionsType 1 Diabetes MellitusArmst:slim X2 with Control-IQ Technology & Dexcom G6 CGM, Control Group
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 2 countries.

Melissa J SchoelwerCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Lauren G KanapkaJaeb Center for Health Research, Tampa, Florida, USA.
R Paul WadwaBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Marc D BretonCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Katrina J RuedyJaeb Center for Health Research, Tampa, Florida, USA.
Laya EkhlaspourDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Gregory P ForlenzaBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Erin C CobryBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Laurel H MesserBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Eda CengizDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Emily JostBarbara Davis Center for Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Lori CarriaDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Emma EmoryCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Liana J HsuDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Stuart A WeinzimerDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Bruce A BuckinghamDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Rayhan A LalDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Mary Clancy OliveriCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Craig C KollmanCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Betsy B DokkenTandem Diabetes Care, San Diego, California, USA.
Daniel R CherñavvskyCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Roy W BeckJaeb Center for Health Research, Tampa, Florida, USA.
Mark D DeBoerCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
iDCL Trial Research Group
Jaeb Center for Health Research · USStanford Medicine · USYale University · USUniversity of Virginia · USUniversity of Colorado Anschutz Medical Campus · USTandem Diabetes Care (United States) · USCentre Hospitalier Universitaire de Montpellier · FR

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
K12 Career DevelopmentK12DK094712 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI STECK, ANDREA · 2011 to 2021
$4.5M
Modeling and modulating insulin delivery in automated insulin delivery systems to accommodate for meal compositionsK23DK121942 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EKHLASPOUR, LAYA · 2020 to 2024
$964k
The Optimal Pathway to Implanted Autonomous Insulin DeliveryK23DK122017 · NIDDK · STANFORD UNIVERSITY · PI LAL, RAYHAN · 2020 to 2024
$958k
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS K12 DK094712NIDDK NIH HHS K23 DK121942NIDDK NIH HHS K23 DK122017NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK116074
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Insulin Infusion SystemsAdolescentBlood GlucoseBlood Glucose Self-MonitoringChildHumansHypoglycemic AgentsInsulinBlood GlucoseHypoglycemic AgentsInsulinClosed-loop systemsInsulin pumpTime-in-rangeType 1 diabetes

Identifiers

PMID33689454
PMCPMC8252894
OpenAlexW3135247164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.